140 related articles for article (PubMed ID: 11113544)
61. Characterization of cloned human dopamine D1 receptor-mediated calcium release in 293 cells.
Lin CW; Miller TR; Witte DG; Bianchi BR; Stashko M; Manelli AM; Frail DE
Mol Pharmacol; 1995 Jan; 47(1):131-9. PubMed ID: 7838121
[TBL] [Abstract][Full Text] [Related]
62. A D1/D2 chimeric dopamine receptor mediates a D1 response to a D2-selective agonist.
MacKenzie RG; Steffey ME; Manelli AM; Pollock NJ; Frail DE
FEBS Lett; 1993 May; 323(1-2):59-62. PubMed ID: 8098694
[TBL] [Abstract][Full Text] [Related]
63. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
[TBL] [Abstract][Full Text] [Related]
64. Effects of specific dopamine D1 and D2 receptor antagonists and agonists and neuroleptic drugs on emotional defecation in a rat model of akathisia.
Sachdev PS; Saharov T
Psychiatry Res; 1998 Dec; 81(3):323-32. PubMed ID: 9925183
[TBL] [Abstract][Full Text] [Related]
65. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
Sammut S; Bray KE; West AR
Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
[TBL] [Abstract][Full Text] [Related]
66. Basolateral amygdala modulation of the nucleus accumbens dopamine response to stress: role of the medial prefrontal cortex.
Stevenson CW; Gratton A
Eur J Neurosci; 2003 Mar; 17(6):1287-95. PubMed ID: 12670317
[TBL] [Abstract][Full Text] [Related]
67. D1- and D2-like dopamine receptors are co-localized on the presynaptic varicosities of striatal and nucleus accumbens neurons in vitro.
Wong AC; Shetreat ME; Clarke JO; Rayport S
Neuroscience; 1999 Mar; 89(1):221-33. PubMed ID: 10051231
[TBL] [Abstract][Full Text] [Related]
68. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
69. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
Mittleman G; Rosner AL; Schaub CL
J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
[TBL] [Abstract][Full Text] [Related]
70. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.
Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR
Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394
[TBL] [Abstract][Full Text] [Related]
71. Heterologous sensitization of adenylate cyclase is protein kinase A-dependent in Cath.a differentiated (CAD)-D2L cells.
Johnston CA; Beazely MA; Vancura AF; Wang JK; Watts VJ
J Neurochem; 2002 Sep; 82(5):1087-96. PubMed ID: 12358756
[TBL] [Abstract][Full Text] [Related]
72. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
LaHoste GJ; Marshall JF
Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
[TBL] [Abstract][Full Text] [Related]
73. Efficient functional coupling of the human D3 dopamine receptor to G(o) subtype of G proteins in SH-SY5Y cells.
Zaworski PG; Alberts GL; Pregenzer JF; Im WB; Slightom JL; Gill GS
Br J Pharmacol; 1999 Nov; 128(6):1181-8. PubMed ID: 10578130
[TBL] [Abstract][Full Text] [Related]
74. Lithium preferentially inhibits adenylyl cyclase V and VII isoforms.
Mann L; Heldman E; Shaltiel G; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2008 Jun; 11(4):533-9. PubMed ID: 18205980
[TBL] [Abstract][Full Text] [Related]
75. Dopamine depolarizes podocytes via a D1-like receptor.
Bek M; Fischer KG; Greiber S; Hupfer C; Mundel P; Pavenstädt H
Nephrol Dial Transplant; 1999 Mar; 14(3):581-7. PubMed ID: 10193803
[TBL] [Abstract][Full Text] [Related]
76. Allopregnanolone is required for prepulse inhibition deficits induced by D
Mosher LJ; Cadeddu R; Yen S; Staudinger JL; Traccis F; Fowler SC; Maguire JL; Bortolato M
Psychoneuroendocrinology; 2019 Oct; 108():53-61. PubMed ID: 31228750
[TBL] [Abstract][Full Text] [Related]
77. Induction of adenylate cyclase sensitive dopamine D2-receptors in retinoic acid induced differentiated human neuroblastoma SHSY-5Y cells.
Farooqui SM
Life Sci; 1994; 55(24):1887-93. PubMed ID: 7990648
[TBL] [Abstract][Full Text] [Related]
78. Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and beta2 receptors.
Ding G; Wiegerinck RF; Shen M; Cojoc A; Zeidenweber CM; Wagner MB
Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2327-35. PubMed ID: 18375720
[TBL] [Abstract][Full Text] [Related]
79. Dopamine D2 agonists, bromocriptine and quinpirole, increase MPP+ -induced toxicity in PC12 cells.
Chiasson K; Daoust B; Levesque D; Martinoli MG
Neurotox Res; 2006 Aug; 10(1):31-42. PubMed ID: 17000468
[TBL] [Abstract][Full Text] [Related]
80. Neuroprotective potential of Bacopa monnieri and Bacoside A against dopamine receptor dysfunction in the cerebral cortex of neonatal hypoglycaemic rats.
Thomas RB; Joy S; Ajayan MS; Paulose CS
Cell Mol Neurobiol; 2013 Nov; 33(8):1065-74. PubMed ID: 23975094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
